ClinicalTrials.gg
Not yet recruitingNCT06309875PLANCUIDARTEUpdated Mar 13, 2024

Effect of the PLAN CUIDARTE on the Caregiving Competence of People With Heart Failure

A Phase 2 interventional study of PLAN CUIDARTE and Conventional care in Heart Failure, Caregiver Burden and Discharge Plan, sponsored by Universidad de la Sabana. Not yet recruiting at 1 site in Colombia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-13.

Sponsored by Universidad de la Sabana · Phase 2, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 39 studies in Heart Failure with a site in Colombia — 7 open to participants now, 9 under way, 5 of them phase 3. Heart Failure · Colombia.

Planned enrollment
30th of 34
84 · median 3,388
Started
2024
with 2 others
Phase 2
2 of 39
1 open now
Registered
34th of 39
by date
Lead sponsor
2 of 39
Universidad de la Sabana

Among the 39 studies in Heart Failure with a site in Colombia, this one is the 30th largest by planned enrollment of the 34 interventional ones that give a count, is one of 3 that started in 2024, is one of 2 in phase 2, and was the 34th registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

7 of the 39 studies in Heart Failure with a site in Colombia are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Colombia have not opened yet or have stopped. Only those recruiting at a site in Colombia →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Heart Failure with a site in Colombia, or all of them as a file.
02

Study summary

According to the World Health Organization (WHO), by 2021 cardiovascular diseases (CVD) will be a public health problem, among them heart failure (HF), since this is a chronic disease, patients should be competent in their care. Despite the above, according to research conducted in Colombia, 59.7% of people with chronic noncommunicable diseases (NCDs) have a level of care competence considered not optimal; patients report not having sufficient knowledge of the disease or experience feelings of lack of tools for the management of symptoms and the challenges of post-hospitalization.

The objective of the research is to determine the effect of the PLAN CUIDARTE on the caregiving competence of people with HF

Methodology: Pre-posttest randomized clinical trial, with blinding of the participants, where the intervention "PLAN CUIDARTE" is applied and the initial and subsequent caregiving competence is evaluated in the comparison group and in the intervention group for pretest - posttest and between-group comparisons.

Read the detailed description

Eligibility Criteria:

Inclusion criteria

  • Patients over 18 years of age with a diagnosis of HF.
  • Patients with HF who are hemodynamically stable.
  • Patients with SPMSQ - PFERFFER of 0 - 4 errors or 5 errors, patient who has not received primary education.
  • Patient with a PULSES of 6 to 11

Exclusion criteria

  • Patients with heart failure with heart transplantation scheduled in the next 6 months.
  • Patients requiring transfer to an intensive or intermediate care unit.

Outcome Measures:

  • Primary: Caring competence.
  • Secondary: Satisfaction with care
03

Conditions studied

  • Heart Failure
  • Caregiver Burden
  • Discharge Plan
  • Care Transitions
  • Nursing
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients over 18 years of age who are hospitalized and admitted to the institution with a diagnosis of HF decompensation with a time of diagnosis greater than 6 months.
  • Patients who are hemodynamically stable, without alteration of the state of consciousness.

Exclusion criteria

Exclusion Criteria:

  • HF patients who are hospitalized for cardiac transplantation,
  • Who are under palliative management or who, at the time of discharge, have a formal
  • Who have a designated formal caregiver or are discharged to an institution other than home.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
84 participants (estimated)

Study arms

  • Active comparator
    Conventional

    Set of specific activities carried out by the health care team by the health care team at the time of hospital discharge of HF patients: the patients with HF:

    Other: Conventional care

  • Experimental
    PLAN CUIDARTE

    The "PLAN CUIDARTE" is an intervention aimed at addressing the hospital discharge of people with HF, based on the nursing theory of transitions of Afaf Meleis(46) and under the guidelines of Robin Whittemore for the systematic development of complex interventions for experimental type research in nursing. The PLAN CUIDARTE addresses the specific educational needs of HF patients, as established by the patients with HF, as established by international accreditation standards.

    Other: PLAN CUIDARTE

Interventions

  • OtherPLAN CUIDARTE

    Description Plan Cuidarte

  • OtherConventional care

    Description Conventional care

06

What researchers measure

Primary outcomes

  1. Care Competence

    capacity, ability and preparation of the patient or family caregiver to the patient or family caregiver to perform the task of caregiving(4), which is made up of the following five dimensions: knowledge five dimensions: knowledge, uniqueness, instrumental, enjoyment, anticipation and social relationship, uniqueness, instrumental, enjoyment, anticipation and social relationship.

    Time frame: 30 days

07

Study locations

1 site
  • Universidad de Caldas
    Manizales, Caldas 170004., Colombia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2024; primary completion for Jun 2024, 3 months later.

Of 111 non-industry phase 2 interventional studies under Heart Failure, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 66. This study's planned 3 months is below that.

Counting every sponsor, half of 185 studies reached it within 29 months; a quarter within 17 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2024
First posted
Mar 13, 2024
StartEst.
Mar 25, 2024
Primary completionEst.
Jun 25, 2024
CompletionEst.
Nov 12, 2024
Last update
Mar 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06309875
Lead sponsor
Universidad de la Sabana
Collaborators
Universidad de Caldas
Responsible party
Sponsor
First posted
Mar 13, 2024
Start date
Mar 25, 2024 (estimated)
Primary completion
Jun 25, 2024 (estimated)
Completion
Nov 12, 2024 (estimated)
Last update
Mar 13, 2024

Study contacts

Alejandra Fuentes-Ramirez, DR
Contact
alejandra.fuentes@unisabana.edu.co
+573123722107
Gloria Carvajal-Carrascal, DR
Contact
gloria.carvajal@unisabana.edu.co
+57 3115062590

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion